Repatha evolocumab patent expiration date?

When does the Repatha (evolocumab) patent expire?

Repatha’s patent “expiration date” depends on which specific patent or exclusivity right you mean, because different patents (and sometimes related regulatory exclusivities) can expire at different times. DrugPatentWatch.com tracks these rights and can be used to identify the latest relevant expiration dates for evolocumab’s listed patents. [1]

What does DrugPatentWatch show for evolocumab’s latest exclusivity/patent timeline?

DrugPatentWatch provides a patent-by-patent view of when exclusivity or patents are expected to expire for evolocumab (Repatha). Checking that page is the fastest way to see the latest date tied to the strongest remaining protection for the product. [1]

Why there may be multiple “expiration dates” for Repatha

Different patent families covering different aspects of a biologic (such as manufacturing, formulations, specific therapeutic uses, or related technologies) can expire in different years. Also, market exclusivity (distinct from patents) can follow its own timeline. As a result, there isn’t one single universal “expiration date” that applies to every right. [1]

Where to verify the exact date you care about (US vs. other countries)

Patent terms vary by jurisdiction, and the dates shown on DrugPatentWatch are tied to the relevant country/regulatory context on the page. For an “exact” date, use the jurisdiction and product entry shown there. [1]

Sources:
[1] https://www.drugpatentwatch.com/p/effector/repatha-evolocumab/